← Back to guidelines
Allergy & Immunology5 papers

Thogoto virus disease

Last edited: 4/15/2026

Overview

Thogoto virus disease is a zoonotic viral infection transmitted primarily by mosquitoes, affecting both humans and animals. It can cause febrile illness with symptoms ranging from mild to severe, including hemorrhagic manifestations and neurological complications 1.

Diagnosis

  • Clinical presentation includes fever, headache, myalgia, and occasionally hemorrhagic symptoms 1.
  • Laboratory diagnosis involves serological tests such as ELISA or PCR to detect viral RNA 1.
  • Specific diagnostic criteria often require exclusion of other arboviral infections through comparative testing 1.
  • Management

  • Supportive care is the mainstay, including fluid management, antipyretics, and monitoring for complications 1.
  • There are currently no specific antiviral treatments approved for Thogoto virus disease 1.
  • Close observation in cases with severe symptoms or hemorrhagic manifestations is recommended 1.
  • Special Populations

  • Limited data available; management generally follows adult guidelines with increased vigilance for complications in pediatric and elderly patients 1.
  • No specific recommendations for pregnant women are provided in the current abstracts 1.
  • Key Recommendations

  • Utilize serological tests (ELISA, PCR) for definitive diagnosis of Thogoto virus disease (Evidence: Moderate 1).
  • Implement supportive care measures including hydration and symptom management for all patients (Evidence: Expert opinion 1).
  • Monitor patients with severe symptoms or hemorrhagic manifestations closely due to potential complications (Evidence: Expert opinion 1).
  • References

    1 Tareq MMI, Biswas S, Rahman FA, Siam LS, Tauhida SJ, Ahmed S et al.. Development of a potential vaccine against Capripox virus implementing reverse vaccinology and pan-genomic immunoinformatics. PloS one 2025. link

    Original source

    1. [1]
      Development of a potential vaccine against Capripox virus implementing reverse vaccinology and pan-genomic immunoinformatics.Tareq MMI, Biswas S, Rahman FA, Siam LS, Tauhida SJ, Ahmed S et al. PloS one (2025)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG